NDC properties for "Amjevita 80 MG per 0.8 ML Auto-Injector" (RxCUI 2663915)
About this data
The tables show NDC propoerties for Amjevita 80 MG per 0.8 ML Auto-Injector with the RxCUI 2663915
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Amjevita 80 MG per 0.8 ML Auto-Injector (RxCUI 2663915)
| BLA | BLA761024 |
|---|---|
| MMSL_CODE | BD39993 |
| RxCUI | 2663915 |
| SPL_SET_ID | 9c44bd5b-4464-40a4-8933-8680950f00f2 |
| SPL_SET_ID | b7178e36-6787-45ab-8fee-be59bc6a4aa4 |
| SPL_SET_ID | d7862491-2634-4402-b001-dcc1abf8dd58 |
| Prescribable Synonym | AMJEVITA 80 MG in 0.8 ML Auto-Injector |
| RXNAV_STR | Amjevita 80 MG per 0.8 ML Auto-Injector |
| RxNorm Name | 0.8 ML adalimumab-atto 100 MG/ML Auto-Injector [Amjevita] |
| RxNorm Synonym | Amjevita 80 MG per 0.8 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2663915) |
NDC Properties
NDC Item 55513048101
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-01 |
| NDC Item | 55513048101 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-481 |
NDC Item 55513048102
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-02 |
| NDC Item | 55513048102 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-481 |
NDC Item 72511048101
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-01 |
| NDC Item | 72511048101 |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-481 |
NDC Item 72511048102
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-02 |
| NDC Item | 72511048102 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-481 |
NDC Item 84612048101
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-01 |
| NDC Item | 84612048101 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-481 |
NDC Item 84612048102
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-02 |
| NDC Item | 84612048102 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-481 |
NDC Item 55513048101
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-01 |
| NDC Item | 55513048101 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-481 |
NDC Item 55513048102
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-02 |
| NDC Item | 55513048102 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-481 |
NDC Item 72511048101
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-01 |
| NDC Item | 72511048101 |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-481 |
NDC Item 72511048102
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-02 |
| NDC Item | 72511048102 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-481 |
NDC Item 84612048101
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-01 |
| NDC Item | 84612048101 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-481 |
NDC Item 84612048102
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-02 |
| NDC Item | 84612048102 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-481 |
NDC Item 55513048101
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-01 |
| NDC Item | 55513048101 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-481 |
NDC Item 55513048102
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-02 |
| NDC Item | 55513048102 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-481 |
NDC Item 72511048101
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-01 |
| NDC Item | 72511048101 |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-481 |
NDC Item 72511048102
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-02 |
| NDC Item | 72511048102 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-481 |
NDC Item 84612048101
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-01 |
| NDC Item | 84612048101 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-481 |
NDC Item 84612048102
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-02 |
| NDC Item | 84612048102 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-481 |
NDC Item 55513048101
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-01 |
| NDC Item | 55513048101 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-481 |
NDC Item 55513048102
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-02 |
| NDC Item | 55513048102 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-481 |
NDC Item 72511048101
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-01 |
| NDC Item | 72511048101 |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-481 |
NDC Item 72511048102
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-02 |
| NDC Item | 72511048102 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-481 |
NDC Item 84612048101
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-01 |
| NDC Item | 84612048101 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-481 |
NDC Item 84612048102
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-02 |
| NDC Item | 84612048102 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-481 |
NDC Item 55513048101
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-01 |
| NDC Item | 55513048101 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-481 |
NDC Item 55513048102
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-02 |
| NDC Item | 55513048102 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-481 |
NDC Item 72511048101
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-01 |
| NDC Item | 72511048101 |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-481 |
NDC Item 72511048102
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-02 |
| NDC Item | 72511048102 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-481 |
NDC Item 84612048101
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-01 |
| NDC Item | 84612048101 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-481 |
NDC Item 84612048102
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-02 |
| NDC Item | 84612048102 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-481 |
NDC Item 55513048101
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-01 |
| NDC Item | 55513048101 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-481 |
NDC Item 55513048102
| NDC 9 | 55513-481 |
|---|---|
| NDC 10 | 55513-481-02 |
| NDC Item | 55513048102 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-481 |
NDC Item 72511048101
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-01 |
| NDC Item | 72511048101 |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-481 |
NDC Item 72511048102
| NDC 9 | 72511-481 |
|---|---|
| NDC 10 | 72511-481-02 |
| NDC Item | 72511048102 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-481 |
NDC Item 84612048101
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-01 |
| NDC Item | 84612048101 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-481-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-481 |
NDC Item 84612048102
| NDC 9 | 84612-481 |
|---|---|
| NDC 10 | 84612-481-02 |
| NDC Item | 84612048102 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-481-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-481 |